Increased oxidative stress biomarkers in the saliva of Down syndrome patients

Archives of Oral Biology

Volumn 58, Issue 9, 2013, Pages 1246-1250

  Komatsu, Tomoko ^a   Duckyoung, Yoon ^a   Ito, Ayumi ^a   Kurosawa, Kenji ^b   Maehata, Yojiro ^a   Kubodera, Tomoko ^b   Ikeda, Masakazu ^a   Lee, Masaichi Chnag Il ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

8 OHdG; Down syndrome; Oxidative stress; Periodontal disease; Saliva

Indexed keywords

8 HYDROXY 2' DEOXYADENOSINE; 8-HYDROXY-2'-DEOXYADENOSINE; BIOLOGICAL MARKER; DEOXYADENOSINE DERIVATIVE;

8-OHDG; ADOLESCENT; ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CHILD; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTIUM; PHYSIOLOGY; PRESCHOOL CHILD; SALIVA;

8-OHDG; DOWN SYNDROME; OXIDATIVE STRESS; PERIODONTAL DISEASE; SALIVA;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEOXYADENOSINES; DOWN SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERIODONTIUM; SALIVA;

EID: 84881312963     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2013.03.017     Document Type: Article

References (38)

1. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355(9199):165-9.
2. Gibson PA, Newton RW, Selby K, Price DA, Leyland K, Addison GM. Longitudinal study of thyroid function in Down's syndrome in the first two decades. Archives of Disease in Childhood 2005;90(6):574-8.
3. Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clinical and Experimental Immunology 2009;156(2):189-93.
4. Pelz J, Kunze J. Down's syndrome in infants of diabetic mothers. Archives of Disease in Childhood 1998;79(2):199-200.
5. Lott IT, Head E. Down syndrome and Alzheimer's disease: a link between development and aging. Mental Retardation and Developmental Disabilities Research Reviews 2001;7(3): 172-8.
6. Smith DS. Health care management of adults with Down syndrome. American Family Physician 2001;64(6):1031-8.
7. Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. European Journal of Public Health 2007;17(2):221-5.
8. Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist 2009;14(2):164-73.
9. Nualart Grollmus ZC, Morales Chavez MC, Silvestre Donat FJ. Periodontal disease associated to systemic genetic disorders. Medicina Oral Patologia Oral y Cirugia Bucal 2007;12(3):E211-5.
10. Amano A, Kishima T, Akiyama S, Nakagawa I, Hamada S, Morisaki I. Relationship of periodontopathic bacteria with early-onset periodontitis in Down's syndrome. Journal of Periodontology 2001;72(3):368-73.
11. Levanon D, Lieman-Hurwitz J, Dafni N, Wigderson M, Sherman L, Bernstein Y, et al. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO Journal 1985;4(1): 77-84.
12. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proceedings of the National Academy of Sciences of the United States of America 1987;84(22):8044-8.
13. Lee M, Hyun D, Jenner P, Halliwell B. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. Journal of Neurochemistry 2001;76(4):957-65.
14. Komatsu T, Lee MC, Miyagi A, Shoji H, Yoshino F, Maehata Y, et al. Reactive oxygen species generation in gingival fibroblasts of Down syndrome patients detected by electron spin resonance spectroscopy. Redox Report 2006;11(2):71-7.
15. Fisher-Wellman K, Bell HK, Bloomer RJ. Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxidative Medicine and Cellular Longevity 2009;2(1):43-51.
16. Bahar M, Khaghani S, Pasalar P, Paknejad M, Khorramizadeh MR, Mirmiranpour H, et al. Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutrition Journal 2010;9:62.
17. Elahi MM, Kong YX, Matata BM. Oxidative stress as a mediator of cardiovascular disease. Oxidative Medicine and Cellular Longevity 2009;2(5):259-69.
18. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators of Inflammation 2010:453892.
19. Lee C, Miura K, Liu X, Zweier JL. Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite. Journal of Biological Chemistry 2000;275(50):38965-72.
20. Pallardo FV, Degan P, d'Ischia M, Kelly FJ, Zatterale A, Calzone R, et al. Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology 2006;7(4):211-20.
21. Chen HI, Liou SH, Ho SF, Wu KY, Sun CW, Chen MF, et al. damage estimated by plasma 8-hydroxydeoxyguanosine (8-OHdG): influence of 4, 4′- methylenebis (2-chloroaniline) exposure and smoking. Journal of Occupational Health 2007;49(5):389-98.
22. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clinica Chimica Acta 2004;339(1-2):1-9.
23. Campos C, Guzman R, Lopez-Fernandez E, Casado A. Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome. Biochimica et biophysica acta 2008;1812(7):760-8.
24. Takane M, Sugano N, Ezawa T, Uchiyama T, Ito K. A marker of oxidative stress in saliva: association with periodontally-involved teeth of a hopeless prognosis. Journal of Oral Science 2005;47(1):53-7.
25. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta odontologica Scandinavica 1963;21:533-51.
26. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. Journal of Periodontology 1999;70(1):13-29.
27. Song MF, Li YS, Ootsuyama Y, Kasai H, Kawai K, Ohta M, et al. Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. Free Radical Biology & Medicine 2009;47(1):41-6.
28. Kaufman E, Lamster IB. The diagnostic applications of saliva-a review. Critical Reviews in Oral Biology and Medicine 2002;13(2):197-212.
29. Hofman LF. Human saliva as a diagnostic specimen. Journal of Nutrition 2001;131(5):1621S-5S.
30. Branson BM. FDA approves OraQuick for use in saliva, on March 25, the FDA approved the first rapid test for HIV in oral fluids. AIDS Clinical Care 2004;16(5):39.
31. Hayakawa M, Hattori K, Sugiyama S, Ozawa T. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochemical and Biophysical Research Communications 1992;189(2):979-85.
32. Sawamoto Y, Sugano N, Tanaka H, Ito K. Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiology and Immunology 2005;20(4):216-20.
33. Yasuda M, Ide H, Furuya K, Yoshii T, Nishio K, Saito K, et al. Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadism. Journal of Sexual Medicine 2008;5(6):1482-91.
34. Khocht A, Janal M, Turner B. Periodontal health in Down syndrome: contributions of mental disability, personal, and professional dental care. Special Care in Dentistry 2010;30(3):118-23.
35. Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clinical and Experimental Immunology 2011;164(1):9-16.
36. Shukkur EA, Shimohata A, Akagi T, Yu W, Yamaguchi M, Murayama M, et al. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Human Molecular Genetics 2006;15(18): 2752-62.
37. Ceballos I, Nicole A, Briand P, Grimber G, Delacourte A, Flament S, et al. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome. Free Radical Research Communications 1991;12/13(Pt. (2)):581-9.
38. Jovanovic SV, Clements D, MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radical Biology & Medicine 1998;25(9):1044-8.